Lince Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Acecannacecann.cominOct 2021 · $15M
AceCann cultivates, processes, and extracts medical cannabis products aimed at the European market.
BiotechHealthtech
Co-investorsAmaral Family InvestmentsBlueCrow CapitalCasa Verde Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.